This specific expression pattern together with its de–regulation and functional role in a set of human cancers puts MSI1 in row with other bona fide oncofetal RBPs such as IGF2BP1 and 3, LIN28B or MEX proteins, representing diagnostic markers with therapeutic potential for cancer treatment [4,53,54,55,56]. Here, IGF2BP1 is linked to cancer.